Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
(6β,16α,17α)-16,17-Epoxy-6-methoxy-3,4-cyclo-16,17-dihydroabiraterone is an impurity of Abiraterone (A108490), a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.